- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Robert Nelsen
- Location
- Chicago, IL
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Robert Nelsen.
Follow Filing Activity
Follow Robert Nelsen and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Robert Nelsen
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRME | Prime Medicine, Inc. | Common Stock, $0.00001 par value | 10% | $80,853,607 | 18,587,036 | Robert Nelsen | 07 Aug 2025 | ||
| VIR | Vir Biotechnology, Inc. | Common Stock, $0.0001 par value | 8.5% | $101,645,627 | 13,534,704 | Robert Nelsen | 27 Feb 2026 |
Schedules 13D/G Reported by Robert Nelsen:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.